A Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of AZD8931 In Combination with Anastrozole, Compared to An-astrozole alone, in Post menopausal Women With Hormone Receptor positive, Endocrine T

Cancer type: Breast cancer

Phase: II

Principal Investigator: Bono Petri

Country: FI

Keywords: Finland

Status: Inclusion completed

Link to